Ultragenyx Pharmaceutical (RARE) Cash from Financing Activities (2013 - 2025)
Ultragenyx Pharmaceutical (RARE) posted Cash from Financing Activities of $394.19 million for Q4 2025, compared with $2.95 million a year earlier.
Ultragenyx Pharmaceutical (RARE) Cash from Financing Activities (2013 - 2025) Analysis & Trends
For FY2025, Ultragenyx Pharmaceutical's Cash from Financing Activities came in at $478 million, up 19.8% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Cash from Financing Activities was $399 million in FY2024 (+2.8%), $388 million in FY2023 (-22.6%), $501.21 million in FY2022 (+322.8%) and $118.55 million in FY2021 (-80.3%).
- The Q4 2025 figure stands as the highest quarterly Cash from Financing Activities since Q3 2022.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2023, with growth of 465.7%; the weakest was Q4 2024, with a decline of 99.1%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$192,000 (Q3 2025), $83.84 million (Q2 2025) and $157,000 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 394.19 Mn |
| Sep 30, 2025 | -192,000.00 |
| Jun 30, 2025 | 83.84 Mn |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 2.95 Mn |
| Sep 30, 2024 | 11.17 Mn |
| Jun 30, 2024 | 384.94 Mn |
| Mar 31, 2024 | -58,000.00 |
| Dec 31, 2023 | 330.47 Mn |
| Sep 30, 2023 | 25.23 Mn |
| Jun 30, 2023 | 33.02 Mn |
| Mar 31, 2023 | -722,000.00 |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | 491.88 Mn |
| Jun 30, 2022 | 5.84 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 85.73 Mn |
| Sep 30, 2021 | 7.55 Mn |
| Jun 30, 2021 | 12.63 Mn |
| Mar 31, 2021 | 12.65 Mn |
Ultragenyx Pharmaceutical Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RARE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();